share_log

4: Statement of changes in beneficial ownership of securities-Officer Glover Stephen C.

4: Statement of changes in beneficial ownership of securities-Officer Glover Stephen C.

4：持股变动声明-高管 Glover Stephen C.
美股SEC公告 ·  2024/07/19 09:36

Moomoo AI 已提取核心信息

Stephen C. Glover, the Chief Executive Officer of ZyVersa Therapeutics, Inc. (ZVSA), was involved in a transaction with the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, the number of shares held by Glover after the transaction remains unknown.
Stephen C. Glover, the Chief Executive Officer of ZyVersa Therapeutics, Inc. (ZVSA), was involved in a transaction with the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, the number of shares held by Glover after the transaction remains unknown.
2023年5月24日，ZyVersa Therapeutics公司（ZVSA）的首席执行官Stephen C. Glover与公司的股票进行了交易。交易的具体细节，包括交易的股份数量、股份的性质、交易价格以及交易的总价值，在公告中没有公开披露。因此，Glover在交易后持有的股份数量仍未知。
2023年5月24日，ZyVersa Therapeutics公司（ZVSA）的首席执行官Stephen C. Glover与公司的股票进行了交易。交易的具体细节，包括交易的股份数量、股份的性质、交易价格以及交易的总价值，在公告中没有公开披露。因此，Glover在交易后持有的股份数量仍未知。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间